Ribavirin targets eIF4E dependent Akt survival signaling-Reference-Cited by-同舟云学术

Ribavirin targets eIF4E dependent Akt survival signaling

Published:2008-10 Issue:3 Volume:375 Page:341-345
ISSN:0006-291X
Container-title:Biochemical and Biophysical Research Communications
language:en
Short-container-title:Biochemical and Biophysical Research Communications

Author:

Tan Keith,Culjkovic Biljana,Amri Abdellatif,Borden Katherine L.B.

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry,Biophysics

Reference25 articles.

1. Translational control and metastatic progression: enhanced activity of the mRNA cap-binding protein eIF-4E selectively enhances translation of metastasis-related mRNAs;Graff;Clin. Exp. Metastasis,2003

2. Tumor-specific RNAi targeting eIF4E suppresses tumor growth, induces apoptosis and enhances cisplatin cytotoxicity in human breast carcinoma cells;Dong;Breast Cancer Res. Treat.,2008

3. Therapeutic suppression of translation initiation factor eIF4E expression reduces tumor growth without toxicity;Graff;J. Clin. Invest.,2007

4. Survival signalling by Akt and eIF4E in oncogenesis and cancer therapy;Wendel;Nature,2004

5. Controlling gene expression through RNA regulons: the role of the eukaryotic translation initiation factor eIF4E;Culjkovic;Cell Cycle,2007

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Regulation of Eukaryotic Translation Initiation Factor 4E as a Potential Anticancer Strategy;Journal of Medicinal Chemistry;2023-09-19

2. Glioblastoma as a Novel Drug Repositioning Target: Updated State;Anti-Cancer Agents in Medicinal Chemistry;2023-07

3. Dual targeting of protein translation and nuclear protein export results in enhanced antimyeloma effects;Blood Advances;2023-06-27

4. A Review: PI3K/AKT/mTOR Signaling Pathway and Its Regulated Eukaryotic Translation Initiation Factors May Be a Potential Therapeutic Target in Esophageal Squamous Cell Carcinoma;Frontiers in Oncology;2022-04-28

5. Repurposing of Antimicrobial Agents for Cancer Therapy: What Do We Know?;Cancers;2021-06-26